The chronic kidney disease market growth is being driven by the rising global prevalence of diabetes, hypertension, and aging populations. Increasing awareness and earlier diagnosis are expanding the ...

The chronic kidney disease market growth is being driven by the rising global prevalence of diabetes, hypertension, and aging populations. Increasing awareness and earlier diagnosis are expanding ...

Australia - AstraZeneca Secures Interlocutory Injunction Against Generic Dapagliflozin Entry. Legal News and Analysis - ...

Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its audited results for the year ended 31 Decemb ...

For decades, Consumer Reports has presented 10 Top Picks among new vehicles, spotlighting the cars, SUVs, and trucks that shine brightest in our extensive road tests and exclusive member surveys. They ...

Researchers from Thomas Jefferson University have discovered that combining two diabetes drugs—dapagliflozin and exenatide—can keep blood sugar levels under control for people with type 2 diabetes, ...

Farxiga is a prescription oral tablet used to manage type 2 diabetes or certain heart or kidney conditions. It’s a brand-name drug with the active ingredient dapagliflozin. Farxiga tablets come in ...

Objective: This analysis compared the efficacy and safety of the sodium-glucose cotransporter-2 (SGLT2) inhibitor, dapagliflozin, and the dipeptidyl peptidase-4 (DPP4) inhibitor, saxagliptin, both ...

Background: Euglycemic Diabetic Ketoacidosis (EDKA) is a rare but well-known adverse effect of sodium glucose transporter 2 (SGLT-2) inhibitors. This class of antidiabetic medications has ketogenic ...